| P2093 | author name string | Win-Kuang Shen | |
| | Hon-Chi Lee | |
| | Kristin Tl Huang | |
| P2860 | cites work | The effect of age on serum albumin in healthy males: report from the Normative Aging Study | Q68250200 |
| | Age-associated changes in the components of atrioventricular conduction in apparently healthy volunteers | Q68775862 |
| | Aging, Total Body Potassium, Fat-free Mass, and Cell Mass in Males and Females Between Ages 18 and 85 Years | Q69377354 |
| | Orthostatic hypotension in the elderly | Q69537035 |
| | CaATPase content is lower in cardiac sarcoplasmic reticulum isolated from old rats | Q70729165 |
| | The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics | Q71064706 |
| | Influence of aging on the oxidative and conjugative metabolism of propranolol | Q71628047 |
| | Changes in heart rate variability with age | Q71837278 |
| | Age-related changes in beta-adrenergic neuroeffector systems in the human heart | Q72193269 |
| | Age associated changes in membrane currents in rat ventricular myocytes | Q72722207 |
| | Gastric Emptying Rate in the Elderly: Implications for Drug Therapy | Q72891378 |
| | A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial | Q73180786 |
| | Predictors of loss of lung function in the elderly: the Cardiovascular Health Study | Q73513147 |
| | In vivo age-related changes in hepatic drug-oxidizing capacity in humans | Q77731268 |
| | Alterations in properties of L-type Ca channels in aging rat heart | Q77912846 |
| | THE EFFECT OF INCREASING AGE ON THE DISTRIBUTION OF PERIPHERAL BLOOD FLOW IN MAN | Q78273811 |
| | Atrial fibrillation in the elderly | Q80380868 |
| | Not so fast: intrinsic heart rate vs. beta-adrenergic responsiveness in the aging human heart | Q81285856 |
| | Drug metabolism and ageing | Q81876189 |
| | Sodium current function in adult and aged canine atrial cells | Q83159125 |
| | Sarcolemmal K(ATP) channels in ageing | Q35791882 |
| | Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community | Q35885942 |
| | Implantable cardioverter-defibrillators should be used routinely in the elderly | Q36645671 |
| | Ageing and the liver | Q36682915 |
| | Amiodarone for atrial fibrillation | Q36747976 |
| | Polypharmacy and the geriatric patient. | Q36802997 |
| | Decreased maximal heart rate with aging is related to reduced {beta}-adrenergic responsiveness but is largely explained by a reduction in intrinsic heart rate | Q36808246 |
| | The current state of knowledge on age, sex, and their interactions on clinical pharmacology | Q36818908 |
| | Pharmacokinetic-pharmacodynamic crisis in the elderly | Q36949673 |
| | Antiarrhythmics: elimination and dosage considerations in hepatic impairment | Q37008809 |
| | Pharmacokinetics and drug metabolism in the elderly | Q37514319 |
| | Review on pharmacokinetics and pharmacodynamics and the aging kidney | Q37670496 |
| | Updates on cytochrome p450-mediated cardiovascular drug interactions | Q37699864 |
| | Cardiovascular drugs inducing QT prolongation: facts and evidence | Q37704450 |
| | Age-related changes in pharmacokinetics | Q37865566 |
| | Increased risk of digoxin toxicity following hospitalization | Q38385334 |
| | Aging and determinants of hepatic drug clearance | Q38599007 |
| | Reduced β-adrenoceptor sensitivity in the elderly | Q39256290 |
| | Comparative pharmacokinetic changes and drug therapy in an older population. | Q40245100 |
| | Mechanisms of adenosine-mediated actions on cellular and clinical cardiac electrophysiology | Q40597046 |
| | Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology | Q41531498 |
| | Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide | Q41609798 |
| | Digoxin in the elderly: Pharmacokinetic consequences of old age | Q41617375 |
| | Disopyramide-induced urinary retention | Q42585729 |
| | Action potential prolongation in cardiac myocytes of old rats is an adaptation to sustain youthful intracellular Ca2+ regulation. | Q44021114 |
| | Spanish pacemaker registry. 6th official report of the Spanish Society of Cardiology Working Group on Cardiac Pacing (2008). | Q44275030 |
| | Baroreflex buffering is reduced with age in healthy men. | Q44382968 |
| | Calcium and potassium currents in cells from adult and aged canine right atria | Q44472818 |
| | Cardiac arrhythmias on 24-h ambulatory electrocardiography in older women and men: the Cardiovascular Health Study | Q44699323 |
| | Declining into failure: the age-dependent loss of the L-type calcium channel within the sinoatrial node | Q46939081 |
| | Impact of age on QT interval and QT dispersion in healthy subjects: a regression analysis. | Q47944949 |
| | Expressional analysis of the cardiac Na-Ca exchanger in rat development and senescence | Q48008665 |
| | Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments] | Q48295531 |
| | Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography | Q49146276 |
| | Expression of sarcoplasmic reticulum Ca(2+)-ATPase and calsequestrin genes in rat heart during ontogenic development and aging. | Q52235127 |
| | Ageing-related changes of connexins and conduction within the sinoatrial node. | Q52858881 |
| | Prevalence of cardiovascular diseases among older adults. The Cardiovascular Health Study. | Q52885876 |
| | Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. | Q53338757 |
| | Severe Brochostenosis by Oral Propafenone Immediately After Commencing Treatment. | Q54192338 |
| | Effects of aging on 24-h dynamic baroreceptor control of heart rate in ambulant subjects | Q57489534 |
| | Risk factor implications of incidentally discovered uncomplicated bundle branch block | Q57647961 |
| | Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages | Q63321261 |
| | Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance Program | Q67464691 |
| | Comparison of paracetamol metabolism in young adult and elderly males | Q67969797 |
| | Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology | Q24598754 |
| | Epidemiology of sudden cardiac death: clinical and research implications | Q24650947 |
| | Interactions between grapefruit juice and cardiovascular drugs | Q28284805 |
| | Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial | Q28300531 |
| | Age-related down-regulation of HCN channels in rat sinoatrial node | Q28579448 |
| | Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study | Q29614197 |
| | Prediction of creatinine clearance from serum creatinine | Q29615603 |
| | Pharmacodynamics in older adults: a review | Q30444966 |
| | Cardiac pacing in the elderly | Q33153626 |
| | Drug-related syncope | Q33168093 |
| | Cardiovascular pharmacology of aging | Q33545454 |
| | Age-dependent changes of the kidneys: pharmacological implications | Q33719234 |
| | Structural remodelling of the sinoatrial node in obese old rats | Q33754290 |
| | Cardiac aging in mice and humans: the role of mitochondrial oxidative stress | Q33806910 |
| | Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction | Q33970406 |
| | Medication misadventures in the elderly: a year in review. | Q33995477 |
| | Antiarrhythmic agents: drug interactions of clinical significance | Q34122414 |
| | Digoxin | Q34128151 |
| | The anatomy and physiology of the sinoatrial node--a contemporary review | Q34143598 |
| | Human alpha-1-glycoprotein and its interactions with drugs | Q34331335 |
| | Calculation of the estimated creatinine clearance in avoiding drug dosing errors in the older patient | Q34380297 |
| | The effect of ageing on the hepatic clearance of propranolol | Q34517399 |
| | Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group | Q34558054 |
| | Use of cardiovascular medications in the elderly | Q34809362 |
| | Pacing therapy in the elderly | Q34818042 |
| | The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype | Q34843826 |
| | Clinical practice. Preventing falls in elderly persons | Q35037755 |
| | Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease | Q35049811 |
| | Aged atria: electrical remodeling conducive to atrial fibrillation | Q35095072 |
| | Cardiovascular drug therapy in the elderly: theoretical and practical considerations | Q35113299 |
| | Changes in renal function with aging. Implications for treatment | Q35364174 |
| | Drug metabolism and ageing | Q35747971 |
| P433 | issue | 3 | |
| P304 | page(s) | 184-194 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | Journal of Geriatric Cardiology | Q15765238 |
| P1476 | title | Use of antiarrhythmic drugs in elderly patients | |
| P478 | volume | 8 | |